CA2219277A1 — Novel tetracycline derivatives
Assigned to Pfizer Ltd Great Britain · Expires 1996-11-07 · 30y expired
What this patent protects
The present invention relates to novel tetracycline derivatives, to intermediates used in their preparation, to pharmaceutical compositions containing them and to their medicinal use. The active compounds of the present invention are useful in the prevention, treatment or control…
USPTO Abstract
The present invention relates to novel tetracycline derivatives, to intermediates used in their preparation, to pharmaceutical compositions containing them and to their medicinal use. The active compounds of the present invention are useful in the prevention, treatment or control of bacterial infections in warm-blooded animals.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.